Skip to main content
. 2019 Jan-Feb;23(1):9–13. doi: 10.4103/ijem.IJEM_244_18

Table 2.

Details of SGLT2 inhibitors

SGLT2i prescribed Observation
Empagliflozin (%) 104 (50.7)
 10 mg 74 (71.1)
 25 mg 30 (28.9)
Canagliflozin (%) 62 (30.2)
 100 mg 60 (96.8)
 300 mg 2 (3.2)
Dapagliflozin (%) 39 (19.1)
 5 mg 8 (20.5)
 10 mg 31 (79.5)
Duration of treatment with SGLT2i (months)
 Mean±SD 7.6±5.9
 Range 1-36